Nigerian Gender Rights Advocate and Lawyer, Omowumi Ogunrotimi, Honored with the 2025 Global Citizen Prize

Renowned Nigerian gender rights advocate and lawyer, Omowumi Ogunrotimi has been honored with the prestigious 2025 Global Citizen Prize at an award ceremony held in New York City on Wednesday, April 30, 2025.

Omowumi was celebrated alongside other distinguished changemakers: Valeriia Rachynska of Ukraine, Taily Terena of Brazil, and Lydia Amenyaglo of Ghana, in recognition of their outstanding contributions to advancing equity and justice in their respective communities.

Omowumi Ogunrotimi’s recognition is a global acknowledgment of her impactful work and footprints in the gender ecosystem including leading the advocacy effort that resulted in the passage of the Anti-Sexual Harassment Bill by the Federal House of Representatives and the localization of sexual harassment prevention frameworks by 26 sub-national governments.

The high-profile event attracted global attention and was attended by world leaders, policy influencers, and human rights advocates. Notable dignitaries present included United Nations Deputy Secretary-General Amina J. Mohammed, Sarah, Duchess of York, celebrated science educator Bill Nye, and Professor José Manuel Barroso, Chair of the Gavi Board.

Pope Francis, the 266th pope of the Roman Catholic Church, passed away at the age of 88 on April 21, 2025, at his residence in Vatican City. His death was officially announced by Cardinal Kevin Farrell during a Vatican Media broadcast. Pope Francis, born Jorge Mario Bergoglio in Argentina, made history in 2013 as the first Latin American and Jesuit pope. He was deeply admired around the world for his humility, progressive reforms, and strong advocacy for social justice, climate action, and interfaith dialogue.

During his papacy, he worked to modernize the Church, promote inclusivity, and reach out to marginalized communities. His leadership style was simple and compassionate, often choosing to live modestly and focus on people-centered issues. Following his death, global leaders, including India's Prime Minister Narendra Modi, expressed their sorrow and praised his legacy. The Vatican has now entered a period known as sede vacante (the vacant seat), and preparations are underway for the conclave that will elect the next pope.
⚠️⚠️⚠️
Disclaimer: NO COPYRIGHT INFRINGEMENT INTENDED!
We do not own the rights to this video and photo used in this reel and post. All credit goes to the original creator. This video is shared for informational purposes only. If you are the owner and wish to discuss this content, please DM or email us.

FAIR USE: Copyright disclaimer under section 107 of the copyright act 1976. Allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship infringing." We do not own all the material.
.
.
.
#news
#worldnews
#worldinlast24hr
#explore
#explorepage
#trending

Advocates say gender-based violence is being ignored during the election campaign.

Angela Lynch, executive officer of the Queensland Sexual Assault Network, told Radio National Breakfast that there has been silence.

"It sends a message to our community, because it hasn't been a priority, that it's really not a national priority as [previously] stated," she said.

Australia's two major political parties may be "resting on their commitment to the national plan", the domestic violence prevention advocate added.

While she said a national plan is important in providing "a blueprint for action", she underlined that it is "simply not enough".

"We know that the violence is increasing. We know that the reports of rape and sexual violence are increasing every year.

"Four women were killed last week in relation to gender-based violence.

"We really need to double down on our efforts … we need to find new solutions if we're going to end this in a generation, which both parties and all governments around Australia have promised."

Family and domestic violence support services:
If you need help immediately call emergency services on triple-0
Full Stop Australia: 1800 385 578
1800 Respect National Helpline: 1800 737 732
DV Connect Women's Line: 1800 811 811
13 YARN 13 92 76
Kids Helpline: 1800 55 1800
Headspace: 1800 650 890
Lifeline (24-hour Crisis Line): 13 11 14

🎧 Hear @abcradionational Breakfast from 5.30am to 9am on the @abclisten app via the link in our bio.

#RadioNationalBreakfast #Crime #Violence #GenderBasedViolence #Women #AustraliaVotes #AusVotes

President Trump announced plans to sign an executive order aimed at reducing U.S. drug prices by implementing a "Most Favored Nation" (MFN) policy. This policy would direct the Department of Health and Human Services to negotiate lower drug prices with pharmaceutical companies, tying U.S. prices to the lowest prices paid by other countries. ⁠
⁠
The order is set to focus on Medicare Part B drugs, which include medications administered in a doctor's office, such as cancer treatments. Trump claims the policy could reduce costs by 30% to 80% and save the U.S. "TRILLIONS OF DOLLARS."⁠
⁠
This latest order is a continuation of Trump's efforts from his first term to address the high cost of U.S. drugs via price controls. In 2020, he signed a similar executive order aimed at tying U.S. drug prices to international benchmarks, but the proposal faced significant opposition from the pharmaceutical industry. Critics argued that such a policy would harm innovation and reduce access to new medications. Trump's 2020 attempt was blocked by a federal court after he left office, preventing its implementation under President Biden. ⁠
⁠
The MFN policy is likely to face similar resistance from the pharmaceutical industry, which argues that forcing lower prices could stifle innovation, leading to fewer new medicines and potentially harming the U.S.'s role as a global leader in drug development. ⁠
⁠
Pharmaceutical companies contend that the policy would grant foreign governments excessive influence over U.S. drug pricing, undermining the ability of the U.S. market to set fair and competitive prices. Despite this opposition, the proposal reflects ongoing frustrations with U.S. drug pricing, a long-standing issue that has drawn bipartisan criticism.⁠
⁠
Head to the link in bio for the full story